hcc44 Search Results



hcc 44  (DSMZ)
95
DSMZ hcc 44
Hcc 44, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcc44/pmc12629830-463-0-1?v=DSMZ
Average 95 stars, based on 1 article reviews
hcc 44 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

86
Korean Cell Line Bank hcc44
Hcc44, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcc44/pm31866442-248-107-110?v=Korean+Cell+Line+Bank
Average 86 stars, based on 1 article reviews
hcc44 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Broad Institute Inc hcc44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc44, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcc44/pmc06422029-47-0-3?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
hcc44 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
iCell Bioscience Inc human luad cell lines hcc44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Human Luad Cell Lines Hcc44, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcc44/pmc11982721-113-7-17?v=iCell+Bioscience+Inc
Average 90 stars, based on 1 article reviews
human luad cell lines hcc44 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Bioarray Inc hcc44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc44, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcc44/pmc11372373-360-46-51?v=Bioarray+Inc
Average 90 stars, based on 1 article reviews
hcc44 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CH Instruments hcc-44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc 44, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hcc44/pm37832808-75-8-14?v=CH+Instruments
Average 90 stars, based on 1 article reviews
hcc-44 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, HCC44, H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: (A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, HCC44, H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques: Inhibition

(A) IB of the indicated proteins in A549, H1944, HCC44, H2009, H441, and H358 cells treated with or without 500 nM JQ1 for 24 hr. Red cell lines, KL; blue cell lines, KP.

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: (A) IB of the indicated proteins in A549, H1944, HCC44, H2009, H441, and H358 cells treated with or without 500 nM JQ1 for 24 hr. Red cell lines, KL; blue cell lines, KP.

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques:

(A) Crystal violet staining of A549, H1944, HCC44, H23, H2009, H1792, H441, and mouse embryonic fibroblast (MEF) cells In the presence of 2.5 μM MMB and 10 nM Tram each day and/or 500 nM JQ1 every other day (intermittent) for 12 days (See STAR Methods). Red cell lines, KL and KLP; blue cell lines, KP (upper). Quantification of extracted crystal violet in MMB + Tram + JQ1 treated cells was normalized to Tram + JQ1 treated cells (n = 3) (lower).

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: (A) Crystal violet staining of A549, H1944, HCC44, H23, H2009, H1792, H441, and mouse embryonic fibroblast (MEF) cells In the presence of 2.5 μM MMB and 10 nM Tram each day and/or 500 nM JQ1 every other day (intermittent) for 12 days (See STAR Methods). Red cell lines, KL and KLP; blue cell lines, KP (upper). Quantification of extracted crystal violet in MMB + Tram + JQ1 treated cells was normalized to Tram + JQ1 treated cells (n = 3) (lower).

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques: Staining

KEY RESOURCES TABLE

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques: Control, Recombinant, Enzyme-linked Immunosorbent Assay, Cell Viability Assay, shRNA, Negative Control, Software, Binding Assay, Expressing